About The Position

The Senior Medical Director, Global Medical Affairs – CD38 Pipeline will play a key strategic role within Biogen’s Global Medical organization. Reporting to the Head of Global Medical Nephrology, Transplant and CD38 Pipeline, this individual will lead medical strategy for new, non-nephrology/non transplant indications for the anti-CD38 pipeline for other immune mediated diseases driven by pathogenic antibody production. The role focuses on shaping the medical perspective for pipeline programs by integrating disease‑area expertise, scientific insights, and evolving treatment paradigms to inform development strategy and long‑term asset positioning. The individual will work closely with Research, Clinical Development, and cross‑functional partners to ensure the CD38 pipeline programs are aligned with unmet medical needs and future clinical practice.

Requirements

  • Advanced degree (MD, PhD, PharmD, or equivalent) in a scientific or clinical discipline.
  • Minimum of 10+ years of experience in the biopharmaceutical industry.
  • At least 5 years of experience supporting pipeline or early‑stage asset strategy.
  • Deep scientific expertise in immunology and autoimmune disease biology
  • Ability to synthesize complex scientific and clinical information into strategic medical insights.
  • Experience working in cross‑functional environments across research, development, and medical teams.
  • Strong communication and presentation skills.

Nice To Haves

  • Experience contributing to pipeline portfolio strategy or therapeutic area strategy.
  • Familiarity with early asset development (Phase 2+) and clinical trial strategy including Target Product Profiles.
  • Strong understanding of competitive landscapes and evolving standards of care in immunology.
  • Experience engaging with external scientific experts and academic investigators to gain insights to inform medical strategies.

Responsibilities

  • Lead development of global medical strategies for the CD38 pipeline indications including evidence generation and KME engagement strategy.
  • Lead or contribute to the development of indication specific publication strategies and scientific narrative development.
  • Partner with Research, Clinical Development and Commercial to shape Target Product Profiles (TPPs) and medical differentiation strategies.
  • Maintain a deep understanding of competitive landscapes and evolving standards of care in the pipeline indications.
  • Engage with external scientific experts and investigators to inform CD38 pipeline strategy.
  • Collaborate across Global Medical Affairs, Clinical Development, and Commercial teams to integrate medical insights and provide sound medical perspectives for cross functional deliverables including market research.
  • Support internal governance discussions by synthesizing scientific and clinical information into clear strategic perspectives.

Benefits

  • Medical, Dental, Vision, & Life insurances
  • Fitness & Wellness programs including a fitness reimbursement
  • Short- and Long-Term Disability insurance
  • A minimum of 15 days of paid vacation and an additional end-of-year shutdown time off (Dec 26-Dec 31)
  • Up to 12 company paid holidays + 3 paid days off for Personal Significance
  • 80 hours of sick time per calendar year
  • Paid Maternity and Parental Leave benefit
  • 401(k) program participation with company matched contributions
  • Employee stock purchase plan
  • Tuition reimbursement of up to $10,000 per calendar year
  • Employee Resource Groups participation
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service